VF
RYTM icon

Virtu Financial’s Rhythm Pharmaceuticals RYTM Stock Holding History

Virtu Financial’s Portfolio RYTM Stock Details RYTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-26,501
Closed -$1.22M – 2004
2023
Q4 		$1.22M Buy
+26,501
New +$836K 0.1% 174
2023
Q3 		– Sell
-13,188
Closed -$217K – 1816
2023
Q2 		$217K Buy
+13,188
New +$238K 0.02% 768
2022
Q3 		– Sell
-22,666
Closed -$94K – 2169
2022
Q2 		$94K Buy
+22,666
New +$124K 0.01% 970
2018
Q3 		– Sell
-6,501
Closed -$203K – 2089
2018
Q2 		$203K Buy
+6,501
New +$178K 0.01% 1503

Other funds holding RYTM

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return

Virtu Financial's RYTM Position: Q1 2024 in Review

Virtu Financial sold out of Rhythm Pharmaceuticals (RYTM) in Q1 2024, closing a stake of 26,501 shares — an estimated $1.22M sold.

Virtu Financial first reported a position in RYTM in Q2 2018 and held it in 4 quarters. The position peaked at $1.22M in Q4 2023. 167 funds tracked by Wall St. Rank hold RYTM as of Q1 2024.

  • Virtu Financial reported no remaining Rhythm Pharmaceuticals position as of Q1 2024 after selling out during the quarter.
  • Virtu Financial sold 26,501 Rhythm Pharmaceuticals shares in Q1 2024, an estimated $1.22M.
  • Virtu Financial first reported a position in Rhythm Pharmaceuticals in Q2 2018 and held it in 4 quarters.
  • Virtu Financial's Rhythm Pharmaceuticals position peaked at $1.22M in Q4 2023.
  • 167 funds tracked by Wall St. Rank held Rhythm Pharmaceuticals as of Q1 2024.

Based on Virtu Financial's 13F filing for Q1 2024, filed 20 May 2024.